Black and Hispanic patients with advanced lung cancer less likely than Whites to get new immunotherapy
Approval of immunotherapy for advanced lung cancer by the Food and Drug Administration (FDA) led to a significant increase in its use, but this did not eliminate disparities among users that were apparent prior to approval. The FDA approval process typically takes around 7 years, but clinical trials, compassionate use, and other agreements mean that […]